Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease.

@article{Molnar2014AngiotensinconvertingEI,
  title={Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease.},
  author={Miklos Z Molnar and Kamyar Kalantar-Zadeh and Evan H. Lott and Jun Ling Lu and Sandra M. Malakauskas and Jennie Z Ma and Darryl Leigh Quarles and Csaba Pal Kovesdy},
  journal={Journal of the American College of Cardiology},
  year={2014},
  volume={63 7},
  pages={
          650-658
        }
}
OBJECTIVES The study objective was to assess the association between angiotensin-converting enzyme inhibitor (ACEI)/angiotensin receptor blocker (ARB) use and mortality in patients with chronic kidney disease (CKD). BACKGROUND There is insufficient evidence about the association of ACEI or ARBs with mortality in patients with CKD. METHODS A logistic regression analysis was used to calculate the propensity of ACEI/ARB initiation in 141,413 U.S. veterans with nondialysis CKD who were… CONTINUE READING
BETA
Tweets
This paper has been referenced on Twitter 9 times. VIEW TWEETS

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 37 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 44 REFERENCES

Similar Papers

Loading similar papers…